Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it is better positioned in several key areas than before COVID-19 due to investments, lessons learned, and structural changes. Significant gaps remain in coordination, sustained funding, state/local capabilities, workforce, supply chains, detection systems, and public trust, leaving the country vulnerable.[1][2]
Progress Since COVID-19
The Biden-Harris Administration (and prior efforts) took concrete steps that improved readiness:
GAO and others note that implementing remaining recommendations from hundreds of COVID-related reviews would further strengthen systems.[8]
Persistent Gaps and Expert Assessments
Multiple bipartisan and independent reviews conclude the US remains underprepared:
Current Tests and Broader Context
H5N1 avian influenza (spreading in cattle/poultry with limited human cases) serves as a live stress test: Surveillance and PPE/antiviral distribution have functioned, but challenges in monitoring exposed persons, testing scale, and coordination highlight limits. Mpox responses also revealed distribution and equity issues. Emerging biotech (e.g., AI-enabled engineering) raises deliberate/accidental risks that current systems are not fully optimized for.[13][12]
Pandemics are inevitable (“when, not if”). COVID killed over 1 million Americans; a worse pathogen (higher lethality/transmissibility) or concurrent crises (climate disasters, cyber, conflict) would strain systems further. Healthcare surge capacity, hospital staffing, and primary care access remain constrained even in normal times.
Bottom Line and Path Forward
The US has stronger stockpiles, better data infrastructure, advanced platform technologies, dedicated coordination offices, and hard-won experience than in early 2020. It can detect and begin responding faster in many scenarios. However, it is not adequately prepared for a major, novel, or multi-wave crisis without further reforms—leadership clarity, sustained multi-year funding (beyond emergency supplements), SLTT capacity-building, resilient domestic supply chains, improved detection/indoor protections, workforce pipelines, equity focus, and rebuilding trust.[1][8]
Experts across bipartisan commissions, GAO, National Academies, TFAH, and others urge implementing outstanding recommendations (e.g., reauthorize/strengthen PAHPA, full biodefense strategy execution, countermeasure “warm bases,” BioWatch replacement). Without sustained political will and investment, the “panic and neglect” cycle risks repeating, with potentially higher costs in lives and economy. Readiness is a continuous process, not a destination.
Citations (13)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Significant gaps remain in coordination, sustained funding, state/local capabilities, workforce, supply chains, detection systems, and public trust, leaving the country vulnerable.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Significant gaps remain in coordination, sustained funding, state/local capabilities, workforce, supply chains, detection systems, and public trust, leaving the country vulnerable.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “It has supported responses to H5N1, mpox, and other outbreaks.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC has advanced forecasting/modeling and lab partnerships (“warm bases”).”
- https://bidenwhitehouse.archives.gov/wp-content/uploads/2024/04/Global-Health-Security-Strategy-2024-1.pdf
Backs: “US underwent a WHO Joint External Evaluation (JEE) in September 2024 using the post-COVID tool (3rd edition), showing strong capacities in many of the 19 technical areas (e.g., high scores in immunization, lab systems, emergency response operations in available data), with recommendations focused on refinements.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “US underwent a WHO Joint External Evaluation (JEE) in September 2024 using the post-COVID tool (3rd edition), showing strong capacities in many of the 19 technical areas (e.g., high scores in immunization, lab systems, emergency response operations in available data), with recommendations focused on refinements.”
- https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/
Backs: “Faster vaccine/therapeutics scale-up experience from COVID; nurse licensure compact expansion for surge staffing; some public health workforce investments via American Rescue Plan.”
- https://www.gao.gov/products/gao-24-107175
Backs: “GAO and others note that implementing remaining recommendations from hundreds of COVID-related reviews would further strengthen systems.”
- https://www.axios.com/2024/05/07/biodefense-buildup-urged-exclusive-report
Backs: “COVID exposed failures that earlier recommendations (if fully implemented) could have mitigated.”
- https://www.prnewswire.com/news-releases/nation-dangerously-unprepared-for-deadly-outbreaks-and-biological-attacks-302136825.html
Backs: “COVID exposed failures that earlier recommendations (if fully implemented) could have mitigated.”
- https://www.cidrap.umn.edu/smallpox/national-academies-report-says-us-not-ready-intentional-accidental-smallpox-outbreak
Backs: “H5N1 response has shown monitoring/testing capacity in most jurisdictions but personnel/funding shortages for exposure tracking and variable antiviral stockpiles.”
- https://jamanetwork.com/journals/jama/fullarticle/2819159
Backs: “H5N1 response has shown monitoring/testing capacity in most jurisdictions but personnel/funding shortages for exposure tracking and variable antiviral stockpiles.”
- https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Global Health Security Index and others historically ranked the US high on paper but real-world COVID performance was poor relative to peers.”